McGuire Investment Group LLC Buys 502 Shares of Thermo Fisher Scientific Inc. $TMO

McGuire Investment Group LLC raised its stake in Thermo Fisher Scientific Inc. (NYSE:TMO) by 1.5% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 33,679 shares of the medical research company’s stock after buying an additional 502 shares during the period. Thermo Fisher Scientific comprises about 1.7% of McGuire Investment Group LLC’s investment portfolio, making the stock its 16th biggest position. McGuire Investment Group LLC’s holdings in Thermo Fisher Scientific were worth $13,656,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors have also recently made changes to their positions in the stock. Naples Global Advisors LLC increased its holdings in shares of Thermo Fisher Scientific by 14.6% in the 2nd quarter. Naples Global Advisors LLC now owns 866 shares of the medical research company’s stock worth $352,000 after buying an additional 110 shares during the last quarter. Hudson Value Partners LLC bought a new position in shares of Thermo Fisher Scientific in the 2nd quarter worth $3,754,000. Community Financial Services Group LLC grew its holdings in shares of Thermo Fisher Scientific by 6.4% during the 2nd quarter. Community Financial Services Group LLC now owns 743 shares of the medical research company’s stock valued at $301,000 after purchasing an additional 45 shares during the last quarter. B.O.S.S. Retirement Advisors LLC grew its holdings in shares of Thermo Fisher Scientific by 10.1% during the 2nd quarter. B.O.S.S. Retirement Advisors LLC now owns 590 shares of the medical research company’s stock valued at $239,000 after purchasing an additional 54 shares during the last quarter. Finally, Trust Co. of Vermont grew its holdings in shares of Thermo Fisher Scientific by 0.3% during the 2nd quarter. Trust Co. of Vermont now owns 46,616 shares of the medical research company’s stock valued at $18,901,000 after purchasing an additional 126 shares during the last quarter. Institutional investors own 89.23% of the company’s stock.

Insider Activity at Thermo Fisher Scientific

In related news, CEO Marc N. Casper sold 10,000 shares of Thermo Fisher Scientific stock in a transaction dated Friday, August 22nd. The shares were sold at an average price of $500.96, for a total transaction of $5,009,600.00. Following the completion of the transaction, the chief executive officer directly owned 115,174 shares of the company’s stock, valued at $57,697,567.04. This trade represents a 7.99% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, CAO Joseph R. Holmes sold 385 shares of Thermo Fisher Scientific stock in a transaction dated Friday, August 29th. The shares were sold at an average price of $492.63, for a total transaction of $189,662.55. Following the transaction, the chief accounting officer directly owned 2,319 shares of the company’s stock, valued at approximately $1,142,408.97. This trade represents a 14.24% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 30,066 shares of company stock valued at $14,182,963 in the last three months. Company insiders own 0.33% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts recently commented on TMO shares. HSBC reaffirmed a “hold” rating and set a $510.00 target price on shares of Thermo Fisher Scientific in a report on Thursday, July 24th. UBS Group increased their target price on shares of Thermo Fisher Scientific from $460.00 to $500.00 and gave the company a “neutral” rating in a report on Thursday, July 24th. Wells Fargo & Company dropped their price target on shares of Thermo Fisher Scientific from $570.00 to $565.00 and set an “overweight” rating for the company in a research report on Thursday, July 24th. Royal Bank Of Canada set a $561.00 price target on shares of Thermo Fisher Scientific and gave the company an “outperform” rating in a research report on Tuesday, September 2nd. Finally, Evercore ISI dropped their price target on shares of Thermo Fisher Scientific from $500.00 to $480.00 and set an “outperform” rating for the company in a research report on Tuesday, July 8th. Fifteen equities research analysts have rated the stock with a Buy rating and five have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $583.53.

Thermo Fisher Scientific Trading Up 9.6%

NYSE:TMO opened at $531.69 on Thursday. The company has a 50-day moving average price of $480.27 and a 200-day moving average price of $447.56. Thermo Fisher Scientific Inc. has a 12 month low of $385.46 and a 12 month high of $616.57. The company has a current ratio of 1.93, a quick ratio of 1.50 and a debt-to-equity ratio of 0.65. The stock has a market cap of $200.77 billion, a price-to-earnings ratio of 30.75, a P/E/G ratio of 2.63 and a beta of 0.77.

Thermo Fisher Scientific (NYSE:TMO) last posted its earnings results on Wednesday, July 23rd. The medical research company reported $5.36 EPS for the quarter, topping the consensus estimate of $5.22 by $0.14. Thermo Fisher Scientific had a net margin of 15.24% and a return on equity of 16.82%. The firm had revenue of $10.86 billion during the quarter, compared to analysts’ expectations of $10.68 billion. During the same period last year, the company posted $5.37 EPS. The company’s quarterly revenue was up 2.9% compared to the same quarter last year. Thermo Fisher Scientific has set its Q3 2025 guidance at 5.460-5.510 EPS. FY 2025 guidance at 22.220-22.840 EPS. Equities analysts predict that Thermo Fisher Scientific Inc. will post 23.28 EPS for the current year.

Thermo Fisher Scientific Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, October 15th. Investors of record on Monday, September 15th will be given a dividend of $0.43 per share. This represents a $1.72 dividend on an annualized basis and a yield of 0.3%. The ex-dividend date of this dividend is Monday, September 15th. Thermo Fisher Scientific’s dividend payout ratio (DPR) is 9.95%.

Thermo Fisher Scientific Company Profile

Thermo Fisher Scientific Inc provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets.